Recently, several HMGB1, RAGE and TLR4 blocking/inhibiting strategies have been shown to be effective in relieving inflammation in COPD in experimental studies, which will be discussed below. This evidence concerns the gene TLR4 and chronic obstructive pulmonary disease.